ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)

China · Delayed Price · Currency is CNY

37.98

+5.47 (16.83%)

Jun 29, 2026, 3:04 PM CST

-22.38% (1Y)

Market Cap	17.04B -22.9%
Revenue (ttm)	940.78M -21.9%
Net Income	199.99M
EPS	0.44
Shares Out	448.53M
PE Ratio	85.79
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	26,896,747
Open	34.36
Previous Close	32.51
Day's Range	31.99 - 38.32
52-Week Range	29.31 - 81.48
Beta	0.68
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 24, 2026

About SHE:300723

ApicHope Pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of pharmaceutical drugs in China. The company offers pediatric medicines, such as fuganlin and yiqi jianpi oral liquids, carboxymestrine oral solutions, and xiao’er kechuanling oral liquid products; and clindamycin palmitate hydrochloride dispersible tablets, acetylkitasamycin for suspension, qinxiangqingjie oral liquids, epinastine hydrochloride granules, clindamycin palmitate hydrochloride granules, clindamyxin hydrochloride for injection, clind... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2002

Employees 1,294

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300723

Full Company Profile

Financial Performance

In 2025, SHE:300723's revenue was 932.27 million, a decrease of -35.72% compared to the previous year's 1.45 billion. Losses were -337.79 million, -37.45% less than in 2024.

Financial Statements